Trials / Completed
CompletedNCT07003204
Neutrophil-to Lymphocyte and Monocyte-to-Lymphocyte Ratios in Exudative Pleural Effusion
Diagnostic and Prognostic Role of Pleural Fluid Neutrophil-to Lymphocyte and Monocyte-to-Lymphocyte Ratios in Exudative Pleural Effusion
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (actual)
- Sponsor
- Alexandria University · Academic / Other
- Sex
- All
- Age
- 18 Months
- Healthy volunteers
- Not accepted
Summary
Exudative pleural effusion (EPE) presents a diagnostic challenge, requiring accurate biomarkers to predict outcomes and guide treatment. The neutrophil-to-lymphocyte ratio (NLR) and monocyte-to-lymphocyte ratio (MLR) in pleural fluid are emerging as potential prognostic markers. We aimed to assess the diagnostic and prognostic utility of pleural fluid NLR and MLR in EPE.
Detailed description
Pleural fluid NLR and MLR are reliable biomarkers for diagnosing malignant pleural effusion and predicting poorer survival outcomes. These ratios may be useful in clinical practice, especially in resource-limited settings, to guide decision-making in the management of pleural effusions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | medical thoracoscopy | pleural fluid aspiration and cellular analysis |
Timeline
- Start date
- 2025-05-11
- Primary completion
- 2025-05-25
- Completion
- 2025-05-26
- First posted
- 2025-06-04
- Last updated
- 2025-06-04
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT07003204. Inclusion in this directory is not an endorsement.